AppTrim
120 ct
Dietary management of obesity, morbid obesity, and metabolic syndrome
A weight-management encapsulated medical food intended to support appetite control and metabolism under physician supervision. AppTrim addresses the neurochemical imbalances that drive overeating and metabolic dysfunction rather than relying on stimulants or appetite suppressants.
Key differentiator
Best positioned for weight-management support and appetite control in obesity or metabolic syndrome
Suggested retail
$54.95
Clinical Details
How It Works
AppTrim supplies amino acid precursors that modulate neurotransmitter activity involved in appetite regulation and metabolic function. The formulation targets the neurochemical deficits linked to obesity and metabolic syndrome.
Dosage
2 capsules twice daily mid-morning and mid-afternoon; may add 2 capsules in the evening; take without food.
Safety
No significant drug interactions reported. Non-stimulant formulation. Ingredients are GRAS. Use under physician supervision.
Evidence Summary
Clinical deck plus formulation sheet plus public pageA six-week randomized placebo-controlled trial demonstrated statistically significant appetite reduction and body-fat reduction in the AppTrim group versus placebo.
Published Research
Peer-reviewed studies supporting AppTrim.
Ready to offer AppTrim to your patients?
Set up your branded storefront in under 5 minutes. Our AI handles everything else.
See it in action